Patents by Inventor Philip Bland-Ward

Philip Bland-Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES, COMBINATIONS COMPRISING ANTIBODIES, BIOMARKERS, USES & METHODS
    Publication number: 20240122985
    Abstract: The present invention relates to combinations comprising anti-human OX40L antibodies, new biomarkers of autoimmune or alloimmune diseases, and their use in various therapeutic methods.
    Type: Application
    Filed: September 1, 2023
    Publication date: April 18, 2024
    Inventors: Philip BLAND-WARD, Leslie KEAN, Victor TKACHEV
  • Antibodies, combinations comprising antibodies, biomarkers, uses and methods
    Patent number: 11779604
    Abstract: The present invention relates to combinations comprising anti-human x OX40L antibodies, new biomarkers of autoimmune or alloimmune deseases, and their use in various therapeutic methods.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: October 10, 2023
    Assignee: KYMAB LIMITED
    Inventors: Philip Bland-Ward, Leslie Kean, Victor Tkachev
  • SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHD
    Publication number: 20220372153
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Application
    Filed: April 20, 2022
    Publication date: November 24, 2022
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell
  • ANTIBODIES, COMBINATIONS COMPRISING ANTIBODIES, BIOMARKERS, USES & METHODS
    Publication number: 20190275084
    Abstract: The present invention relates to combinations comprising anti-human OX40L antibodies, new biomarkers of autoimmune or alloimmune deseases, and their use in various therapeutic methods.
    Type: Application
    Filed: November 3, 2017
    Publication date: September 12, 2019
    Inventors: Philip BLAND-WARD, Leslie KEAN, Victor TKACHEV
  • Synergistic combinations of OX40L antibodies for the treatment of GvHD
    Patent number: 9868789
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: January 16, 2018
    Assignee: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell
  • Synergistic combinations of OX40L antibodies for the treatment of GvHD
    Patent number: 9868790
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: January 16, 2018
    Assignee: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell
  • SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHD
    Publication number: 20170327586
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Application
    Filed: July 27, 2017
    Publication date: November 16, 2017
    Applicant: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell
  • SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHD
    Publication number: 20170260279
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Application
    Filed: May 24, 2017
    Publication date: September 14, 2017
    Applicant: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell
  • SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHD
    Publication number: 20170037137
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Application
    Filed: October 25, 2016
    Publication date: February 9, 2017
    Applicant: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell
  • Synergistic combinations of OX40L antibodies for the treatment of GVHD
    Patent number: 9512229
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: December 6, 2016
    Assignee: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell
  • SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHD
    Publication number: 20160264675
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Application
    Filed: April 29, 2016
    Publication date: September 15, 2016
    Applicant: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell, Leslie Susan Keen, Victor Tkachev
  • Anti-human OX40L antibodies and methods of treating graft versus host disease with the same
    Patent number: 9434785
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Grant
    Filed: November 9, 2015
    Date of Patent: September 6, 2016
    Assignee: Kymab Limited
    Inventors: Philip Bland-Ward, Jamie Campbell, Steve Holmes, Ian Kirby, Miha Kosmac, Leslie Susan Kean, Victor Tkachev
  • Specific Binding Members For Ngf
    Publication number: 20080107658
    Abstract: Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralise NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.
    Type: Application
    Filed: January 24, 2006
    Publication date: May 8, 2008
    Inventors: Ruth Franks, Andrew Buchanan, Albert Thom, Fraser Welsh, Philip Bland-Ward, Matthew Sleeman, Carl Matthews, Celia Hart, Jon Hawkinson